ovascular Diseases, 20(9), 656–661. 9.Wald, D. S., et al. (2011). Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ, 343, d519. 10. Pan, M. H., et al. (2011). Synergistic interactions of dietary bioactive components reduce risk of cancer. Journal of Functional Foods, 3(4), 238–246. 11. Demonty, I., et al. (2009). Continuous doseresponse relationship of the LDL-cholesterol–lowering effect of phytosterol intake. Journal of Nutrition, 139(2), 271–284. 12. AbuMweis, S. S., et al. (2008). Plant sterol consumption frequency affects plasma lipid levels and cholesterol kinetics in humans. European Journal of Clinical Nutrition, 62(8), 968–974. 13. Brusq, J. M., et al. (2006). Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. Journal of Lipid Research, 47(6), 1281–1288. 14. Yin, J., et al. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 57(5), 712–717. 15.Bundy, R., et al. (2008). Artichoke leaf extract (Cynara scolymus) for treating hypercholesterolaemia. Cochrane Database of Systematic Reviews, (4), CD005959. 16. Mollace, V., et al. (2011). Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia, 82(3), 309–316. 17. Gliozzi, M., et al. (2013). The effect of bergamot on statin-induced myopathy in patients with hyperlipidemia. Phytomedicine, 20(6), 512–516. 18.Ried, K., et al. (2013). Effect of garlic on serum lipids: an updated meta-analysis. Nutrition Reviews, 71(5), 282–299. 19.Whitehead, A., et al. (2014). Cholesterollowering effects of oat β-glucan: a metaanalysis of randomized controlled trials. American Journal of Clinical Nutrition, 100(6), 1413–1421. 20.Wald, D. S., et al. (2011). Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ, 343, d519. 21. Cicero, A. F. G., et al. (2016). Nutraceutical combination in dyslipidaemic subjects with metabolic syndrome: a randomized, crossover, controlled clinical trial. Nutrition & Metabolism, 13(1), 1-9. 22. Izzo, A. A., & Ernst, E. (2009). Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs, 69(13), 1777–1798. 23. Pan, G. Y., et al. (2003). The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Medica, 69(7), 632–636. 24.Macan, H., et al. (2006). Pharmacokinetic interactions between garlic supplements and medications. Molecular Nutrition & Food Research, 50(11), 1059–1072. Kapitola: Komplexní přístup k řízení cholesterolu 800 182 572 7:30-16:30 (Pá: do14:00) Vyhlídka 39, 63800 Brno, Česká republika Tel: +420 545 222 863 Fax: +420 545 222 011 www.vitaminy-mineraly.cz Strana 37
RkJQdWJsaXNoZXIy Nzg5MDg=